Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Hemamali Samaratunga; Brett Delahunt; Lars Egevad; John R. Srigley; Athanase Billis; David G. Bostwick; Philippe Camparo; Liang Cheng; David Clouston; James Denham; Bungo Furusato; Arndt Hartmann; Laura Jufe; James Kench; Diane N. Kenwright; Glen Kristiansen; Katia R.M. Leite; Gregory T. MacLennan; Jennifer Merrimen; Holger Moch; Jon Oxley; Chin Chen Pan; Gladell Paner; Jae Ro; Isabell A.M. Sesterhenn; Jonathan Shanks; Michelle Thunders; Toyonori Tsuzuki; Thomas Wheeler; John W. Yaxley; Murali Varma

doi:10.1016/j.pathol.2019.11.001

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Hemamali Samaratunga, Brett Delahunt, Lars Egevad, John R. Srigley, Athanase Billis, David G. Bostwick, Philippe Camparo, Liang Cheng, David Clouston, James Denham, Bungo Furusato, Arndt Hartmann, Laura Jufe, James Kench, Diane N. Kenwright, Glen Kristiansen, Katia R.M. Leite, Gregory T. MacLennan, Jennifer Merrimen, Holger MochJon Oxley, Chin Chen Pan, Gladell Paner, Jae Ro, Isabell A.M. Sesterhenn, Jonathan Shanks, Michelle Thunders, Toyonori Tsuzuki, Thomas Wheeler, John W. Yaxley, Murali Varma

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

32 Citas (Scopus)

Resumen

Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.

Idioma original	English
Páginas (desde-hasta)	192-196
Número de páginas	5
Publicación	Pathology
Volumen	52
N.º	2
DOI	https://doi.org/10.1016/j.pathol.2019.11.001
Estado	Published - feb. 2020
Publicado de forma externa	Sí

Nota bibliográfica

Publisher Copyright:
© 2019 Royal College of Pathologists of Australasia

ASJC Scopus Subject Areas

Pathology and Forensic Medicine

Acceder al documento

10.1016/j.pathol.2019.11.001

Otros archivos y enlaces

Citar esto

Samaratunga, H., Delahunt, B., Egevad, L., Srigley, J. R., Billis, A., Bostwick, D. G., Camparo, P., Cheng, L., Clouston, D., Denham, J., Furusato, B., Hartmann, A., Jufe, L., Kench, J., Kenwright, D. N., Kristiansen, G., Leite, K. R. M., MacLennan, G. T., Merrimen, J., ... Varma, M. (2020). Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology, 52(2), 192-196. https://doi.org/10.1016/j.pathol.2019.11.001

Samaratunga, H, Delahunt, B, Egevad, L, Srigley, JR, Billis, A, Bostwick, DG, Camparo, P, Cheng, L, Clouston, D, Denham, J, Furusato, B, Hartmann, A, Jufe, L, Kench, J, Kenwright, DN, Kristiansen, G, Leite, KRM, MacLennan, GT, Merrimen, J, Moch, H, Oxley, J, Pan, CC, Paner, G, Ro, J, Sesterhenn, IAM, Shanks, J, Thunders, M, Tsuzuki, T, Wheeler, T, Yaxley, JW & Varma, M 2020, 'Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded', Pathology, vol. 52, n.º 2, pp. 192-196. https://doi.org/10.1016/j.pathol.2019.11.001

@article{b73563c0443c4c2bbb062bc9fe247355,

title = "Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded",

abstract = "Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.",

author = "Hemamali Samaratunga and Brett Delahunt and Lars Egevad and Srigley, {John R.} and Athanase Billis and Bostwick, {David G.} and Philippe Camparo and Liang Cheng and David Clouston and James Denham and Bungo Furusato and Arndt Hartmann and Laura Jufe and James Kench and Kenwright, {Diane N.} and Glen Kristiansen and Leite, {Katia R.M.} and MacLennan, {Gregory T.} and Jennifer Merrimen and Holger Moch and Jon Oxley and Pan, {Chin Chen} and Gladell Paner and Jae Ro and Sesterhenn, {Isabell A.M.} and Jonathan Shanks and Michelle Thunders and Toyonori Tsuzuki and Thomas Wheeler and Yaxley, {John W.} and Murali Varma",

note = "Publisher Copyright: {\textcopyright} 2019 Royal College of Pathologists of Australasia",

year = "2020",

month = feb,

doi = "10.1016/j.pathol.2019.11.001",

language = "English",

volume = "52",

pages = "192--196",

journal = "Pathology",

issn = "0031-3025",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

AU - Samaratunga, Hemamali

AU - Delahunt, Brett

AU - Egevad, Lars

AU - Srigley, John R.

AU - Billis, Athanase

AU - Bostwick, David G.

AU - Camparo, Philippe

AU - Cheng, Liang

AU - Clouston, David

AU - Denham, James

AU - Furusato, Bungo

AU - Hartmann, Arndt

AU - Jufe, Laura

AU - Kench, James

AU - Kenwright, Diane N.

AU - Kristiansen, Glen

AU - Leite, Katia R.M.

AU - MacLennan, Gregory T.

AU - Merrimen, Jennifer

AU - Moch, Holger

AU - Oxley, Jon

AU - Pan, Chin Chen

AU - Paner, Gladell

AU - Ro, Jae

AU - Sesterhenn, Isabell A.M.

AU - Shanks, Jonathan

AU - Thunders, Michelle

AU - Tsuzuki, Toyonori

AU - Wheeler, Thomas

AU - Yaxley, John W.

AU - Varma, Murali

PY - 2020/2

Y1 - 2020/2

N2 - Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.

AB - Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.

UR - http://www.scopus.com/inward/record.url?scp=85076507225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076507225&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2019.11.001

DO - 10.1016/j.pathol.2019.11.001

M3 - Review article

C2 - 31843189

AN - SCOPUS:85076507225

SN - 0031-3025

VL - 52

SP - 192

EP - 196

JO - Pathology

JF - Pathology

IS - 2

ER -

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto